NO870770L - FremgangsmŸte for fremstilling av monoklonale antistoffer. - Google Patents

FremgangsmŸte for fremstilling av monoklonale antistoffer.

Info

Publication number
NO870770L
NO870770L NO87870770A NO870770A NO870770L NO 870770 L NO870770 L NO 870770L NO 87870770 A NO87870770 A NO 87870770A NO 870770 A NO870770 A NO 870770A NO 870770 L NO870770 L NO 870770L
Authority
NO
Norway
Prior art keywords
procedure
manufacture
monoclonal antibodies
monoclonal
antibodies
Prior art date
Application number
NO87870770A
Other languages
English (en)
Other versions
NO870770D0 (no
NO174719B (no
NO174719C (no
Inventor
Karl Erik Hellstrom
Joseph P Brown
Ingegerd Hellstrom
Hans Marquardt
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of NO870770D0 publication Critical patent/NO870770D0/no
Publication of NO870770L publication Critical patent/NO870770L/no
Publication of NO174719B publication Critical patent/NO174719B/no
Publication of NO174719C publication Critical patent/NO174719C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO870770A 1986-02-26 1987-02-25 Fremgangsmåte for fremstilling av monoklonale antistoffer NO174719C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/834,172 US5185432A (en) 1986-02-26 1986-02-26 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas

Publications (4)

Publication Number Publication Date
NO870770D0 NO870770D0 (no) 1987-02-25
NO870770L true NO870770L (no) 1987-08-27
NO174719B NO174719B (no) 1994-03-14
NO174719C NO174719C (no) 1994-06-22

Family

ID=25266276

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870770A NO174719C (no) 1986-02-26 1987-02-25 Fremgangsmåte for fremstilling av monoklonale antistoffer

Country Status (28)

Country Link
US (1) US5185432A (no)
JP (1) JPS62220197A (no)
KR (2) KR870008026A (no)
CN (1) CN87100927A (no)
AT (1) AT400577B (no)
AU (1) AU612967B2 (no)
BE (1) BE1000611A5 (no)
CA (1) CA1312025C (no)
CH (1) CH675880A5 (no)
DD (2) DD266028A5 (no)
DE (1) DE3705276A1 (no)
DK (1) DK98187A (no)
ES (1) ES2004245A6 (no)
FI (1) FI870764A (no)
FR (1) FR2596062B1 (no)
GB (1) GB2186885B (no)
GR (1) GR870294B (no)
IE (1) IE60286B1 (no)
IT (1) IT1203511B (no)
LU (1) LU86786A1 (no)
NL (1) NL8700415A (no)
NO (1) NO174719C (no)
NZ (1) NZ219338A (no)
OA (1) OA08485A (no)
PT (1) PT84370B (no)
SE (2) SE467988B (no)
YU (1) YU46189B (no)
ZA (1) ZA869494B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531301A1 (de) * 1985-09-02 1987-03-05 Behringwerke Ag Monoklonale antikoerper gegen tumorassoziierte glykoproteine, verfahren zu ihrer herstellung sowie ihre verwendung
JPH0813840B2 (ja) * 1987-03-31 1996-02-14 協和醗酵工業株式会社 抗ヒト肺腺癌単クロ−ン性抗体
US5134075A (en) * 1989-02-17 1992-07-28 Oncogen Limited Partnership Monoclonal antibody to novel antigen associated with human tumors
US5171665A (en) * 1989-04-17 1992-12-15 Oncogen Monoclonal antibody to novel antigen associated with human tumors
US5342774A (en) * 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
DE69831522T2 (de) 1997-03-03 2006-06-14 Amersham Biosciences Uk Ltd In-situ Zellextraktion und Assay-Verfahren
DE19725133A1 (de) * 1997-06-13 1998-12-17 Micromet Ges Fuer Biomedizinis Nachweis von seltenen Zellen
US20050089918A1 (en) * 1998-02-23 2005-04-28 Amersham Biosciences Uk Limited In-situ cell extraction and assay method
US6117981A (en) * 1999-06-03 2000-09-12 Cytoclonal Pharmaceutics, Inc. Hybridomas for lung cancer marker and monoclonal antibodies thereof
WO2001018021A1 (en) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. B7-like polynucleotides, polypeptides, and antibodies
US6965018B2 (en) 2000-06-06 2005-11-15 Bristol-Myers Squibb Company Antibodies directed to B7-related polypeptide, BSL-2
TWI317285B (en) * 2000-07-28 2009-11-21 Dainippon Sumitomo Pharma Co New use and kit for remedies for cancer
CN101724072B (zh) * 2008-10-27 2013-10-09 谷为岳 一种抗肿瘤的单克隆抗体的序列及应用
GB0916686D0 (en) * 2009-09-23 2009-11-04 Univ Manchester Metropolitan Treatment of cancer
US8802091B2 (en) 2010-03-04 2014-08-12 Macrogenics, Inc. Antibodies reactive with B7-H3 and uses thereof
NZ602161A (en) 2010-03-04 2014-12-24 Macrogenics Inc Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
JPWO2012036094A1 (ja) * 2010-09-17 2014-02-03 独立行政法人産業技術総合研究所 肺癌鑑別マーカー
CN102391992B (zh) * 2011-11-03 2012-08-29 潘世扬 抗人非小细胞肺癌单克隆抗体及其应用
KR102514317B1 (ko) 2016-04-15 2023-03-27 마크로제닉스, 인크. 신규 b7-h3-결합 분자, 그것의 항체 약물 콘쥬게이트 및 그것의 사용 방법
CN111662371B (zh) * 2020-04-30 2023-07-04 美康生物科技股份有限公司 细胞角蛋白19片段抗原及其制备方法和应用
CN112300284B (zh) * 2020-12-29 2021-04-06 慈达(广州)生物技术有限公司 核酸筛选结合抗体检测用于癌症检测中的用途及其制备的试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569788A (en) * 1983-05-18 1986-02-11 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies against non small cell lung cancer
ZA858371B (en) * 1984-11-02 1987-03-25 Oncogen Monoclonal antibodies for human non-small cell lung carcinomas
IL76877A (en) * 1984-11-02 1991-11-21 Oncogen Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies

Also Published As

Publication number Publication date
ATA43587A (de) 1995-06-15
DK98187A (da) 1987-08-27
GB2186885A (en) 1987-08-26
CN87100927A (zh) 1988-10-05
LU86786A1 (fr) 1987-09-15
SE9201529D0 (sv) 1992-05-14
IE870487L (en) 1987-08-26
AU612967B2 (en) 1991-07-25
BE1000611A5 (fr) 1989-02-21
FI870764A (fi) 1987-08-27
IT8719491A0 (it) 1987-02-25
ES2004245A6 (es) 1988-12-16
FR2596062B1 (fr) 1990-06-08
IT1203511B (it) 1989-02-15
PT84370B (pt) 1989-11-10
DD266028A5 (de) 1989-03-22
FR2596062A1 (fr) 1987-09-25
US5185432A (en) 1993-02-09
SE8700805D0 (sv) 1987-02-25
ZA869494B (en) 1987-10-28
YU25787A (en) 1990-12-31
KR870008026A (ko) 1987-09-23
DK98187D0 (da) 1987-02-25
GB8703700D0 (en) 1987-03-25
NZ219338A (en) 1991-11-26
KR900006338B1 (ko) 1990-08-28
NO870770D0 (no) 1987-02-25
NO174719B (no) 1994-03-14
FI870764A0 (fi) 1987-02-23
DD276165A5 (de) 1990-02-14
DE3705276A1 (de) 1987-08-27
IE60286B1 (en) 1994-06-29
SE467988B (sv) 1992-10-12
AU6927287A (en) 1987-08-27
OA08485A (fr) 1988-07-29
GR870294B (en) 1987-06-30
GB2186885B (en) 1990-10-03
CH675880A5 (no) 1990-11-15
SE8700805L (sv) 1987-10-22
KR880010438A (ko) 1988-10-08
YU46189B (sh) 1993-05-28
NL8700415A (nl) 1987-09-16
AT400577B (de) 1996-01-25
PT84370A (en) 1987-03-01
CA1312025C (en) 1992-12-29
SE9201529A0 (sv) 1992-05-14
NO174719C (no) 1994-06-22
JPS62220197A (ja) 1987-09-28

Similar Documents

Publication Publication Date Title
IT8319234A0 (it) Procedimento per la produzione di anticorpi monoclonali umani.
NO870770L (no) FremgangsmŸte for fremstilling av monoklonale antistoffer.
NO163668C (no) Fremgangsmaate for fremstilling av immunogent kompleks.
NO843293L (no) Monoklonale antistoffer, samt fremgangsmaate for fremstilling av slike
DE3885355D1 (de) Monoklonale Antikörper.
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
NO873774D0 (no) Monoklonale eller polyklonale antistoffer.
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
DK717888D0 (da) Monoklonale antistoffer
NO162018C (no) Fremgangsmaate for fremstilling av 4-metyl-5-alkyltiometylimidazoler.
NO163061C (no) Fremgangsmaate til fremstilling av ferromangan.
NO885002L (no) Fremgangsmaate for fremstilling av sialocylglycerolipider.
NO882730L (no) Fremgangsmaate for fremstilling av aminocyklopentyletere.
NO851386L (no) Fremgangsmaate for fremstilling av antigen.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
NO873488L (no) Monoklonale antistoffer.
NO870828D0 (no) Fremgangsmaate for fremstilling av biskarbamater.
NO157422C (no) Fremgangsmaate til fremstilling av anti-t-lymfocytt-globulin.
NO880834D0 (no) Fremgangsmaate for fremstilling av heterocyclyl-2-propyn-1-aminer.
NO166709C (no) Fremgangsmaate for fremstilling av akrylamider.
NO821874L (no) Fremgangsmaate for fremstilling av fenoletere.
NO900092L (no) Et ekspresjonssystem for fremstilling av kimeriske monoklonale antistoffer.
NO881780D0 (no) Monoklonale antistoffer til fibrin.
FI874368A (fi) Anordning foer rengoerning av skor.